Sw Flu Vac: To take or not to take?

[Guest guest]

Ms Anu Garg,

Commissioner cum Health Secretary,

Orissa.

 

Respected Ma'am,

 

The Swine Flu Vaccine has become highly controversial. The controversy is justified for the following ground;

 

1. Why is there so much of media coverage for a disease which is nowhere near the scourge of other diseases prevailing in the country?

2. Doctors are suspecting that the virus is "laboratory bred"

3. The patent of the vaccine was applied for one year before the outbreak.

4. The vaccine manufacturers want immunity from liability in case things go wrong.

5. The WHO wants the vaccine to be mandatory. Dr Margaret Chen has openly confessed that WHO knew that the disease would occur and spread.

6. The vaccine contains mercury and another adjuvant called Squalene, besides serum from sick monkeys.

7. Both mercury and squalene are known and proven immune destroyers.

8. The vaccine is targeting infants, pregnant mothers and the elderly.

9. Vaccine makers are writing to their relatives not to take the vaccine.

10. Nurses in the USA don't want to take the vaccine. We do not know if the doctors too will refuse them.

11. The vaccine is being pushed without adequate safety tests.

12. The WHO wants the vaccine to be mandatory.

13. The USA wants the vaccine to be given at gunpoint.

14. Plans are afoot to fine rejectors by $1000 PER DAY till they take the vaccine.

15. It is known that the swine flu virus mutates rapidly and yet a vaccine will be thrust upon the population which will be a mixture of viruses without any logic.

16. For a hundred Swine Flu deaths nearly one billion tablets of Tamiflu have been obtained.

17. There is absolutely no evidence that Tamiflu will help swine flu patients.

18. All victims who died were on Tamiflu which is known to have very severe sideffects.

19. The vaccine will be administered late October and the WHO again "knows" that there would be an "explosion" of the disease in late November and December.

20. The nasal vaccine planned for children will give the vaccine ingredients direct access to the brain.

21. A nasal vaccine for measles was rejected by ICMR when they realised the vaccine would harm infants.

22. The Indian vaccine manufacturers have been assured of "protection" and also a "steady market".

 

I think these points merit attention. In fact these facts paint the entire medical industry and fraternity in a very viscious shade of black.

 

Would you like to take the vaccine now that you know of the dangers? Don't you think the population of Orissa should be warned?

 

Let us get together and declare Orissa a "Vaccine Free Zone".

 

Yours faithfully,

Jagannath.

 

encl: News report

Letter from an epidemologist.--------Dear Friends, In yet another twist to Swine flu controversy, the big pharma are all set to exploit the situation. They have asked for advance commitment of purchase of vaccine from India apart from relaxing the norms for human trials. When these pharma companies fear losses they ask for advance commitment but when they go for profits they donot even share the formulas even after the expiry of patents, and nobody is there to controll them ! Please see the link below; http://www.deccanhe rald.com/ content/22883/ 2-foreign- firms-ready- try.html Preventive medicines are under various stages of research2 foreign firms ready to try H1N1 vaccineNew Delhi, Sept 2, DH News Service:India has received positive responses from two international H1N1 vaccine manufacturers to carry out a quick limited human trials so that some emergency stock of the H1N1 vaccine is available with the government. However, the government has to commit a minimum, but reasonable purchase order to the company before the firm starts the trial. A government decision is likely this week. A few major global pharmaceutical companies are in the race to develop the H1N1 vaccine including Glaxo Smithklime (GSK), Novartis, Sanofi-Aventis and Baxter.India has approached all four and received response from GSK and Novartis, director- general of Indian Council of

Medical Research (ICMR) Dr V M Katoch told Deccan Herald.Legal requirementOn Tuesday, the ICMR wrote once again to all companies spelling out details of the Indian legal requirement of carrying out a bridging study on several hundred people before their vaccines are given commercial approval by the Drugs Controller General of India.None of the vaccines are available in the market. All are under various stages of research and development. But several countries have signed advanced purchase agreements with these companies to ensure priority supply. The advanced agreement is required because their production capacity is limited, which can meet the global demand. The Indian trial—as and when it happens—will be a ‘bridge study’ in which the H1N1 vaccine’s safety and efficacy will be observed on 400-600 volunteers following an ICMR technical guideline. If trials are successful, an imported H1N1 vaccine may

be available in limited quantity between December 2009 and February 2010. It will be given primarily to doctors, healthcare workers and security personnel. Thanks Dr._______M.B.B.S.,D.H. M.,M.A.E. (Epidemiology)Directorate of Health Safety and Regulation,Himachal Pradesh+9_______ See the Web & #39;s breaking stories, chosen by people like you. Check out Buzz. http://in.buzz. /

All it takes is just one vaccine to forever change your life. - Dawn, mother of vaccine damaged child.

 

See the Web's breaking stories, chosen by people like you. Check out Buzz.